Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Interleukin-33 induces urokinase in human endothelial cells--possible impact on angiogenesis.

Stojkovic S, Kaun C, Heinz M, Krychtiuk KA, Rauscher S, Lemberger CE, de Martin R, Gröger M, Petzelbauer P, Huk I, Huber K, Wojta J, Demyanets S.

J Thromb Haemost. 2014 Jun;12(6):948-57. doi: 10.1111/jth.12581.

2.

Interleukin-33 stimulates GM-CSF and M-CSF production by human endothelial cells.

Montanari E, Stojkovic S, Kaun C, Lemberger CE, de Martin R, Rauscher S, Gröger M, Maurer G, Neumayer C, Huk I, Huber K, Demyanets S, Wojta J.

Thromb Haemost. 2016 Aug 1;116(2):317-27. doi: 10.1160/TH15-12-0917. Epub 2016 May 12.

PMID:
27173404
4.

Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.

Fibbi G, Caldini R, Chevanne M, Pucci M, Schiavone N, Morbidelli L, Parenti A, Granger HJ, Del Rosso M, Ziche M.

Lab Invest. 1998 Sep;78(9):1109-19.

PMID:
9759655
5.

Interleukin-4 stimulates expression of urokinase-type-plasminogen activator in cultured human foreskin microvascular endothelial cells.

Wojta J, Gallicchio M, Zoellner H, Filonzi EL, Hamilton JA, McGrath K.

Blood. 1993 Jun 15;81(12):3285-92.

PMID:
8507866
6.

Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques.

Demyanets S, Konya V, Kastl SP, Kaun C, Rauscher S, Niessner A, Pentz R, Pfaffenberger S, Rychli K, Lemberger CE, de Martin R, Heinemann A, Huk I, Gröger M, Maurer G, Huber K, Wojta J.

Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):2080-9. doi: 10.1161/ATVBAHA.111.231431. Epub 2011 Jul 7.

PMID:
21737781
7.

Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production.

Choi YS, Choi HJ, Min JK, Pyun BJ, Maeng YS, Park H, Kim J, Kim YM, Kwon YG.

Blood. 2009 Oct 1;114(14):3117-26. doi: 10.1182/blood-2009-02-203372. Epub 2009 Aug 6.

PMID:
19661270
8.

Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices.

Kroon ME, Koolwijk P, van Goor H, Weidle UH, Collen A, van der Pluijm G, van Hinsbergh VW.

Am J Pathol. 1999 Jun;154(6):1731-42.

10.

Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells.

van Hinsbergh VW, van den Berg EA, Fiers W, Dooijewaard G.

Blood. 1990 May 15;75(10):1991-8.

PMID:
2140060
11.

A novel interleukin 33/ST2 signaling regulates inflammatory response in human corneal epithelium.

Lin J, Zhang L, Zhao G, Su Z, Deng R, Pflugfelder SC, Li DQ.

PLoS One. 2013 Apr 9;8(4):e60963. doi: 10.1371/journal.pone.0060963. Print 2013.

12.

Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability.

Massaro M, Zampolli A, Scoditti E, Carluccio MA, Storelli C, Distante A, De Caterina R.

Cardiovasc Res. 2010 May 1;86(2):311-20. doi: 10.1093/cvr/cvp375. Epub 2009 Nov 27.

PMID:
19946014
13.

Interferon-alpha 2 counteracts interleukin-1 alpha-stimulated expression of urokinase-type plasminogen activator in human foreskin microvascular endothelial cells in vitro.

Wojta J, Zoellner H, Gallicchio M, Filonzi EL, Hamilton JA, McGrath K.

Lymphokine Cytokine Res. 1994 Apr;13(2):133-8.

PMID:
8061114
14.

Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells.

Wojta J, Kaun C, Breuss JM, Koshelnick Y, Beckmann R, Hattey E, Mildner M, Weninger W, Nakamura T, Tschachler E, Binder BR.

Lab Invest. 1999 Apr;79(4):427-38.

PMID:
10211995
15.

Interleukin-33 acts as a pro-inflammatory cytokine and modulates its receptor gene expression in highly metastatic human pancreatic carcinoma cells.

Schmieder A, Multhoff G, Radons J.

Cytokine. 2012 Nov;60(2):514-21. doi: 10.1016/j.cyto.2012.06.286. Epub 2012 Jul 20.

PMID:
22819319
16.

IL-37 Is a Novel Proangiogenic Factor of Developmental and Pathological Angiogenesis.

Yang T, Lin Q, Zhao M, Hu Y, Yu Y, Jin J, Zhou H, Hu X, Wei R, Zhang X, Yang X, Liu G, Lu P, Xu G, Yang J, Corry DB, Su SB, Liu S, Liu X.

Arterioscler Thromb Vasc Biol. 2015 Dec;35(12):2638-46. doi: 10.1161/ATVBAHA.115.306543. Epub 2015 Oct 29.

PMID:
26515414
17.

Pro-urokinase up-regulates the expression of urokinase-type plasminogen activator (u-PA) in human pulmonary arterial endothelial cells.

Liu Y, Wang C, Yang Y, Hou X, Wang J.

Thromb Res. 2008;121(4):485-91. Epub 2007 Jul 20.

PMID:
17640719
18.

Induction of urokinase-type plasminogen activator receptor by IL-1 beta.

Hasegawa T, Sorensen L, Dohi M, Rao NV, Hoidal JR, Marshall BC.

Am J Respir Cell Mol Biol. 1997 Jun;16(6):683-92.

PMID:
9191470
19.

Effect of oxidative stress on the expression of t-PA, u-PA, u-PAR, and PAI-1 in endothelial cells.

Oszajca K, Bieniasz M, Brown G, Swiatkowska M, Bartkowiak J, Szemraj J.

Biochem Cell Biol. 2008 Dec;86(6):477-86. doi: 10.1139/O08-137.

PMID:
19088796
20.

Effects of rosuvastatin on fibrinolytic system of human umbilical vein endothelial cells in vitro.

He F, Zhao J, Guo R, Liang Y.

Am J Med Sci. 2014 Oct;348(4):319-23. doi: 10.1097/MAJ.0000000000000251.

PMID:
24694789

Supplemental Content

Support Center